V-Card | Print | PDF | Email Page

David B. Alden


(T) +1.216.586.7121
(F) +1.216.579.0212


  • University of Michigan (J.D. magna cum laude 1983; Order of the Coif); Oberlin College (B.A. with honors in Economics 1980; Phi Beta Kappa)

Bar Admissions

  • Ohio; Florida; U.S. Supreme Court; U.S. Courts of Appeals for the Second, Third, Fifth, Sixth, Seventh, Tenth, and Eleventh Circuits; U.S. District Courts for the Northern and Southern Districts of Ohio and Eastern and Western Districts of Arkansas

For decades, Dave Alden's litigation practice has focused on product liability matters and, in particular, on actions involving prescription drugs, medical devices, tobacco, and consumer products. Dave has been pretrial, trial, and appellate counsel in matters throughout the United States. He regularly counsels clients regarding attorney-client privilege and work product issues, and Ohio's attorney-client privilege statute recently was amended as first advocated in Dave's law review article.

Dave has been national coordinating counsel for major clients, including R.J. Reynolds in smoking and health actions and Wyeth in actions involving prescription antidepressants. He represented Bayer in an arbitration challenging Bayer's decision to terminate development of a hemophilia product in which Bayer prevailed on all claims. Dave previously was in-house counsel at a major accounting firm.

Dave coauthored Drug and Device Product Liability Litigation Strategy (Oxford Univ. Press 2d ed. 2018); "Voluntary Client Testimony As A Privilege Waiver: Is Ohio's Law Caught In A Time Warp?," 59(1) Clev. St. L. Rev. 1 (2011); and "The Meaning Of The Parallel Requirements Exception Under Lohr and Riegel," 65(3) N.Y.U. Ann. Surv. Am. L. 545 (2010). Each year since 2011, he has authored the Ohio chapter of Product Liability Desk Reference: A Fifty-State Compendium (Wolters Kluwer 2018).

Dave's pro bono representations include Raymond Towler, who was exonerated based on new DNA testing after 29 years in prison, and Douglas Prade, who was excluded from male DNA found over the murderer's bite on the victim and seeks a new trial.

David Alden